Launch of the MOBILISE-D Project

 

On 11 April, the project MOBILISE-D, a project funded by the European Innovative Medicines Initiative 2 Joint Undertaking, was launched with the aim to revolutionise assessment of mobility loss using digital technology to lead to enhanced clinical trials and better clinical management.

This project will offer many opportunities where the Avicenna Members could contribute to. As a result, the Avicenna Secretariat we will continue to provide update on the project developments, research, activities and events as there.

The project is of particular interest for the Avicenna Members as it will enable clinicians and scientists from academic centres across Europe to collaborate with companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA) to develop, validate, and ensure regulation of better mobility outcomes through a system using small sensors worn on the human’s body..

 

Key Points

MOBILISE-D aims to use wearable sensors to assess the mobility of patients in clinical trials in order to assess the safety and efficacy of a new drug. The overreaching objectives of the project are:

  • The delivery of valid solutions, consisting of data analytics, outcomes and algorithms, for real-world digital mobility assessment
  • The validation of digital outcomes in the prediction of clinical outcome
  • To obtain regulatory support of health stakeholders to establish digital mobility assessment.

Analysis

The project is relevant to Avicenna because of the similarity between wearable sensors and in silico technology: due to their technological nature, the potential to reduce costs and durations along clinical trials provides an argument to include these technologies into the regulatory process

Since wearable sensors are evolving into computer models receiving patient-specific data in order to predict an outcome, technical validation of both technologies will be similar.

Should you be interested in the Mobilise-D project, please feel free to contact Professor Lynn Rochester, co-ordinator of the Mobilise-D Consortium. The Avicenna Secretariat is also in direct contact with the project Communication and Dissemination team, should you need more information.

More information on the Mobilise-D project can be found here with the full list of consortium partners.

Background

MOBILISE-D is funded through a European Union Horizon 2020 Joint Technology Initiative, Innovative Medicine Initiative (EU H2020-JTI-IMI2). The project consists of 35 partners from academia and EFPIA (European Federation of Pharmaceutical Industries and Associations) working in close collaboration to address the technical and clinical challenges.

Sign up for our monthly newsletter!


Sign up